LUCD
Lucid Diagnostics Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.45
+10.81%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 6.69x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.92x
- Price / sales
- 15.89x
- Price / cash flow
- -1.85x
Enterprise value
- Enterprise value
- $78.0M
- EV / sales
- 14.33x
- EV / EBITDA
- -1.52x
- EV / EBIT
- -1.54x
- Market cap
- $86.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026